Literature DB >> 821200

Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbits.

M Pavone-Macaluso, N Gebbia, F Biondo, S Bertolini, G Caramia, F P Rizzo.   

Abstract

The permeability of the bladder mucosa to thiotepa and to the anthraquinonic antibiotics, adriamycin and daunomycin, was investigated both in humans and in experimental animals. Instillations in rabbits were performed either in intact males or in animals with ligated ureters. Absorption of thiotepa was significantly higher than that of the antibiotics both in men and in rabbits. Furthermore, a qualitative difference was observed in rabbits in relation to time and with regard to fixation to vesical tissues. In man, absorption was highest after transurethral surgery. It was also increased in cases with extensive anaplastic tumours or in the presence of acute inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 821200     DOI: 10.1007/BF00256129

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  3 in total

1.  NEW METHOD FOR DETERMINATION OF ALKYLATING AGENTS IN BIOLOGIC FLUIDS.

Authors:  Y L TAN; D R COLE
Journal:  Clin Chem       Date:  1965-01       Impact factor: 8.327

2.  Absorption of drugs from the bladder and intravesical chemotherapy.

Authors:  M Pavone-Macaluso; N Gebbia
Journal:  Urol Res       Date:  1976-04-21

3.  Absorption studies on intraluminal thio-tepa for topical cytostatic treatment of low-stage bladder tumors.

Authors:  G Lunglmayr; K Czech
Journal:  J Urol       Date:  1971-07       Impact factor: 7.450

  3 in total
  9 in total

1.  Chemotherapy of bladder tumours.

Authors:  M Pavone-Macaluso
Journal:  Urol Res       Date:  1978

2.  Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.

Authors:  R J Ballou; W G Simpson; J I Harty; M T Tseng
Journal:  Urol Res       Date:  1986

Review 3.  Intravesical drug delivery. Pharmacokinetic and clinical considerations.

Authors:  M S Highley; A T van Oosterom; R A Maes; E A De Bruijn
Journal:  Clin Pharmacokinet       Date:  1999-07       Impact factor: 6.447

4.  ThioTEPA pharmacokinetics during intravesical chemotherapy and the influence of Tween 80.

Authors:  J R Masters; B J McDermott; W E Jenkins; E Fenwick; P J Shah; A R Mundy; P M Loadman; M C Bibby
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 5.  Effects of bladder resorption on pharmacokinetic data analysis.

Authors:  J T Dalton; M G Weintjes; J L Au
Journal:  J Pharmacokinet Biopharm       Date:  1994-06

6.  Pharmacologic rationale for intravesical N-trifluoroacetyladriamycin-14-valerate (AD 32): a preclinical study.

Authors:  T W Sweatman; R F Parker; M Israel
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 7.  Intravesical treatments of bladder cancer: review.

Authors:  Zancong Shen; Tong Shen; M Guillaume Wientjes; Michael A O'Donnell; Jessie L-S Au
Journal:  Pharm Res       Date:  2008-03-28       Impact factor: 4.200

8.  Systemic influence of intravesical chemotherapy with verapamil.

Authors:  W G Simpson; M T Tseng; J I Harty
Journal:  Urol Res       Date:  1985

9.  Detecting mitomycin C in human plasma during intravesical therapy.

Authors:  K Jauhiainen
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.